Dr. Reddy's Laboratories

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RDY and other ETFs, options, and stocks.

About RDY

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. 

CEO
Erez Israeli
CEOErez Israeli
Employees
27,811
Employees27,811
Headquarters
Hyderabad, Telangana
HeadquartersHyderabad, Telangana
Founded
1984
Founded1984
Employees
27,811
Employees27,811

RDY Key Statistics

Market cap
12.07B
Market cap12.07B
Price-Earnings ratio
18.47
Price-Earnings ratio18.47
Dividend yield
0.50%
Dividend yield0.50%
Average volume
1.79M
Average volume1.79M
High today
$14.46
High today$14.46
Low today
$14.24
Low today$14.24
Open price
$14.40
Open price$14.40
Volume
1.71M
Volume1.71M
52 Week high
$16.17
52 Week high$16.17
52 Week low
$12.26
52 Week low$12.26

RDY News

TipRanks 2d
Dr. Reddy’s Cleared as U.S. DOJ Closes FCPA Inquiry Without Enforcement

The latest update is out from Dr Reddy’s Laboratories ( (RDY) ). On March 6, 2026, Dr. Reddy’s Laboratories announced that the U.S. Department of Justice has c...

TipRanks 3d
Dr. Reddy’s Srikakulam Plant Clears USFDA Inspection With VAI Classification

Dr. Reddy’s Laboratories Ltd. ( (IN:DRREDDY) ) has provided an update. Dr. Reddy’s Laboratories has received the Establishment Inspection Report from the U.S....

Analyst ratings

36%

of 36 ratings
Buy
36.1%
Hold
33.3%
Sell
30.6%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.